BioMerieux to pay $450M for infectious disease Dx firm

France-based bioMerieux has agreed to buy BioFire Diagnostics, maker of the PCR FilmArray used to detect infectious diseases, for $450 million plus debt. The deal, set to be finalized at the close of the fiscal year or early next year, is expected to allow bioMerieux to bolster its presence in the infectious disease testing arena.

View Full Article in:

American City Business Journals · (Raleigh, N.C.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ